Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease

被引:10
|
作者
Cimaz, Rolando [1 ]
Von Scheven, Annette [2 ,3 ]
Hofer, Michael [2 ,3 ]
机构
[1] AOU Meyer, I-50139 Florence, Italy
[2] CHU Vaudois, Lausanne, Switzerland
[3] HUG, Geneva, Switzerland
关键词
pediatric rheumatology; MACROPHAGE-ACTIVATION SYNDROME; RECEPTOR ANTAGONIST ANAKINRA; ADULT STILLS-DISEASE; RHEUMATOID-ARTHRITIS; IL-1; BLOCKADE; DOUBLE-BLIND; OPEN-LABEL; PHASE-II; INTERLEUKIN-18; EFFICACY;
D O I
10.4414/smw.2012.13582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still's disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA). It is an orphan disease with often a chronic course and a major impact on the affected children and their families. This disorder is unique in terms of clinical manifestations, prognosis and response to conventional immunosuppressants. The objectives of this review are to describe SoJIA and emphasise the recent advances in the pathogenesis and treatment, which have transformed the care and the prognosis of this potentially life-threatening paediatric condition.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Neutrophils: Key players in systemic-onset juvenile idiopathic arthritis pathogenesis
    Frager, Florence Allantaz
    Cantrell, Vicky
    Coudert, Benoit
    Banchereau, Jacques
    Pascual, M. Virginia
    CLINICAL IMMUNOLOGY, 2008, 127 : S138 - S138
  • [32] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Takako Miyamae
    Tomoyuki Imagawa
    Shigeki Katakura
    Rumiko Kurosawa
    Masaaki Mori
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 231 - 237
  • [33] PROTEOMIC IDENTIFICATION OF SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS PHENOTYPIC BIOMARKERS
    Gohar, F.
    McArdle, A.
    Jones, M.
    Callan, N.
    Hernandez, B.
    Miranda-Garcia, M.
    Lavric, M.
    Kessel, C.
    Holzinger, D.
    FitzGerald, O.
    Pennington, S. R.
    Foell, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 487 - 487
  • [34] Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
    Yokota, S
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) : 581 - 586
  • [35] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Katakura, S
    Kurosawa, R
    Mori, M
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) : 231 - 237
  • [36] Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus
    Hiroshi Tanaka
    Koji Tsugawa
    Koichi Suzuki
    Ei-shin Oki
    Kazuhito Nonaka
    Shigeru Kimura
    Etsuro Ito
    European Journal of Pediatrics, 2007, 166 : 1053 - 1055
  • [37] MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis
    Lotfy, Hala M.
    Kandil, Manal E.
    Issac, Marianne Samir Makboul
    Salah, Samia
    Ismail, Nagwa Abdallah
    Mawla, Mohamed A. Abdel
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (05) : 549 - 557
  • [38] MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis
    Hala M. Lotfy
    Manal E. Kandil
    Marianne Samir Makboul Issac
    Samia Salah
    Nagwa Abdallah Ismail
    Mohamed A. Abdel Mawla
    Molecular Diagnosis & Therapy, 2014, 18 : 549 - 557
  • [39] Systemic-onset juvenile idiopathic arthritis - Disease course and significance of early clinical and laboratory features
    Singh-Grewal, D
    Bayer, N
    Feldman, BM
    Schneider, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S94 - S94
  • [40] Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant
    Komatsu, Haruki
    Tateno, Akihiko
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (10) : 707 - 709